Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
RN7SL417P is a pseudogene related to the RNA, 7SL (signal recognition particle RNA) family. Pseudogenes are nonfunctional sequences of genomic DNA originally derived from ancestral functional genes; they do not produce functional RNAs or proteins and are not considered therapeutic targets. There is no current evidence that RN7SL417P has a biological role or disease association, and it does not interact with drugs or serve as a biomarker[5][4]. It may be annotated in some databases as associated with conditions like depressive disorder, but this is likely incidental or due to genomic proximity rather than causality. Do not confuse RN7SL417P pseudogene with functional 7SL RNA gene (signal recognition particle RNA), which plays an essential role in protein sorting and cellular signaling[1][3]. Only the functional 7SL RNA is involved in biologically meaningful pathways; the pseudogene is nonfunctional. RN7SL417P is a nonfunctional pseudogene derivative of the 7SL RNA family, not a molecular target, with no evidence for biological activity, drug interaction, or disease relevance[5][4].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on RNA, 7SL, cytoplasmic 417, pseudogene (RN7SL417P).